Allied Market Research
Upcoming Allied Market Research
Duchenne Muscular Dystrophy Market

Duchenne Muscular Dystrophy Market by Product Type (Pain Management Drugs, Corticosteroids, and Non-steroidal Anti-inflammatory drugs (NSAIDs), Application (Mutation Suppression and Exon Skipping Approach), and End User (Hospitals, Home care Settings, and Clinics):Global Opportunity Analysis and Industry Forecast, 2021–2030

Pages: NA
Jul 2022 | 127 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Duchenne Muscular Dystrophy Market

Request Now !

Duchenne muscular dystrophy is a kind of muscular dystrophy. It is a genetic disorder that is characterized by muscle weakness. It is a rare disease that mainly affects males. This condition causes intellectual disability, difficulty in breathing, weakness in muscles, pneumonia, heart failure, mental health disruption, and respiratory failure. This diagnostic care aims to provide individuals with Duchenne muscular dystrophy with accurate and timely therapy.. This type of diagnostic treatment reduces or controls symptoms, but it is not curable . Drugs such as steroids are used to reduce symptoms of duchenne muscular dystrophy and stem cell therapy and gene therapy are also used for its treatment.

Market Scope and Structure Analysis

Report Metric


Market Size Available for Years


  Base Year Considered


  Forecast Period


  Forecast Unit 

  Value (USD)

  Segments Covered

  Product Type, Application, End User, and Region


COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. This highly contagious disease, caused by a virus , is a  severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is transmitted from one person to another. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a pandemic on March 11, 2020.

Pharmaceutical and biotech companies along with governments across  the globe work to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. According to NCBI, out of 116 duchenne muscular dystrophy patients one patient found to be positive for Covid-19 infection. Moreover, commonly used drugs such as Corticosteroids have witnessed a dramatic increase in demand for the management of patients with duchenne muscular dystrophy with COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as there is a shortage of these drugs in many developed countries. Thus, the pharmaceutical and biotechnology industry is expected to experience a significant growth in the future owing to the demand for corticosteroids drugs for COVID-19. This in turn is expected to have a significant impact on the duchenne muscular dystrophy market.

Top Impacting Factors

  • Factors that drive the growth of duchenne muscular dystrophy market are increase in awareness campaigns about duchenne muscular dystrophy disorder,  development of mutation-specific therapies, increase in prevalence of duchenne muscular dystrophy market, rise in number of product pipeline, increase in number of therapies such as Exondys51, Translarna, launch exon skipping technologies, introduction of corticosteroid based anti-inflammatory treatment .
  • Furthermore, increase in healthcare expenditure; availability of skilled professionals; collaborations & partnerships between key players to facilitate drug development; rise in R&D activities to improve quality of drugs; introduced new medicine such as Ataluren to treat children with duchenne muscular dystrophy aged five or older are some factors, which boost the market growth for duchenne muscular dystrophy market.
  • However, high cost of treatment is expected to hinder the market growth.
  • Contrarily, favorable reimbursement policies and support from government for regulatory approval present new pathways in the industry.

Market Trends

New Product Launches to Flourish the Market

In February 2021, Sarepta Therapeutics has received DA approval for Amondys 45 (casimersen injection), it is an antisense oligonucleotide for the treatment of Duchenne Muscular Dystrophy patients. 

In August 2020, NS Pharma, Inc. launched Viltepso (viltolarsen injection) for the treatment of DMD patients who confirmed mutation of Duchenne Muscular Dystrophy gene which is amenable to skipping of exon 53.

In December 2019, Tahio Pharmaceutical launched TAS-205, it is hematopoietic prostaglandin D synthase (HPGDS) inhibitor for the treatment of DMD. TAS-205 exacerbates the inflammatory response in patients of DMD.

Key Benefits of the Report

  • This study presents the analytical depiction of the duchenne muscular dystrophy industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the duchenne muscular dystrophy market share.
  • The current market is quantitatively analyzed from 2021 to 2030 to highlight the growth scenario  of the duchenne muscular dystrophy market.
  • Porter’s Five Forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed duchenne muscular dystrophy market analysis based on competitive intensity and the competition that will take shape in coming years

Questions Answered in the Duchenne Muscular Dystrophy Report

  • Who are the leading market players active in the duchenne muscular dystrophy market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the duchenne muscular dystrophy market?
  • What are the future projections that would help in taking further strategic steps?
  • What is "duchenne muscular dystrophy "?
  • What is "duchenne muscular dystrophy" market prediction in the future?
  • Who are the leading global players in the "duchenne muscular dystrophy" market?
  • What are the current trends and predicted trends of “duchenne muscular dystrophy” market?
  • What are the key benefits of the "duchenne muscular dystrophy "market report?

Key Market Segments

Segments Sub-segments
By Product Type
  • Pain Management Drugs
  • Corticosteroids
  • NSAIDs
By Application
  • Mutation Suppression
  • Exon Skipping approach
By End User
  • Hospitals
  • Home care settings
  • clinics
By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Eli Lilly and Company
  • Pfizer Inc.
  • PTC Therapeutics Inc.
  • Janssen Pharmaceuticals Inc.
  • Bristol-Myers Squibb Company
  • Acceleron Pharma Inc.
  • BioMarin Pharmaceutical Inc.
  • Nippon Shokubai Co., Ltd
  • Lexicon Pharmaceuticals Inc.
  • Tahio Pharmaceutical Co., Ltd
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Duchenne Muscular Dystrophy Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers